Stay updated on EGFR Mutant Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.

Latest updates to the EGFR Mutant Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Nivolumab and Ipilimumab in treating advanced EGFR+ NSCLC, while adding new collaborators and a revision number.SummaryDifference55%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check104 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to EGFR Mutant Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.